Journal
BRITISH JOURNAL OF CANCER
Volume 94, Issue 7, Pages 941-946Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603043
Keywords
target validation; antiproteolytic drug; cancer therapy; drug design; zinc chelation